Toward breathing easier Novavax coronavirus vaccine, Bellerophon COVID-19 therapy near phase I April 8, 2020 By Michael Fitzhugh No Comments Novavax Inc., one of the first biopharma companies to reveal its efforts to develop a SARS-CoV-2 vaccine in January, has identified a prefusion protein for testing in an Australian phase I trial, slated to start in mid-May.Read More